BRIEF-GlaxoSmithKline says gene therapy for immunodeficiency gets positive CHMP recommendation

* Gsk receives positive CHMP opinion in europe for Strimvelis, first gene therapy to treat very rare disease, ADA-SCID
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.